Rosiglitazone has potent anti-inflammatory effects at the cellular and molecular level, and in plasma, in both obese diabetic and nondiabetic patients

Source: Inpharma, Volume 1, Number 1449, 2004-08-07 , pp. 14-14(1)

Publisher: Adis International

Keywords: Rosiglitazone, pharmacodynamics

Document Type: Research article

Publication date: 2004-01-01

• In this: publication
• By this: publisher
• In this Subject: Pharmacology

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers